Consumer Health News

Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion

FDA · Anti-aging/Longevity/Cellular Rejuvenation · 3 min

FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product for Continued U.S. Marketing

2 min